Japan Medical Dynamic Marketing, Oct-Dec (3Q) Ordinary Profit Decreases by 11%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Jan 30, 2025 12:30 pm JST Earnings

7600 Japan Medical Dynamic Marketing, INC. 【J-GAAP】

Earnings Report

Japan Medical Dynamic Marketing, INC. <7600> [TSE Prime] announced its financial results at noon (12:30) on January 30th. The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was 1.19 billion yen, a 2.5% decrease compared to the same period last year. The progress rate toward the full-year plan of 1.85 billion yen was 64.5%, also falling below the five-year average of 73.4%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to grow 6.3% from the same period last year, reaching 0.65 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 0.53 billion yen, a 10.6% decrease compared to the same period last year. The operating profit margin worsened from 9.4% in the same period last year to 8.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	15,624	1,510	1,543	1,138	43.2	75.5	Jan 31, 2023	J-GAAP
Apr - Dec, 2023	16,993	1,183	1,225	732	27.9	66.5	Jan 31, 2024	J-GAAP
Apr - Dec, 2024	18,458	1,229	1,194	879	33.4	64.5	Jan 30, 2025	J-GAAP
YoY	+8.6%	+3.9%	-2.5%	+20.1%	+19.9%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	12,225	1,129	1,210	912	34.7	14	Apr 30, 2024	J-GAAP
Oct - Mar, 2024 Guidance	13,383	1,181	1,186	804	30.5	15	Oct 30, 2024	J-GAAP
YoY	+9.5%	+4.6%	-2.0%	-11.8%	-11.9%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	21,307	2,024	2,043	1,423	54.0	13	Apr 28, 2023	J-GAAP
Mar, 2024	23,177	1,746	1,842	1,271	48.3	14	Apr 30, 2024	J-GAAP
Mar, 2025 Guidance	25,200	1,850	1,850	1,300	49.4	15	Apr 30, 2024	J-GAAP
YoY	+8.7%	+6.0%	+0.4%	+2.3%	+2.2%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	6,041	566	593	373	14.2	9.4	Jan 31, 2024	J-GAAP
Jan - Mar, 2024	6,184	563	617	539	20.5	9.1	Apr 30, 2024	J-GAAP
Apr - Jun, 2024	6,052	366	367	273	10.4	6.0	Jul 30, 2024	J-GAAP
Jul - Sep, 2024	5,765	303	297	223	8.5	5.3	Oct 30, 2024	J-GAAP
Oct - Dec, 2024	6,641	560	530	383	14.6	8.4	Jan 30, 2025	J-GAAP
YoY	+9.9%	-1.1%	-10.6%	+2.7%	+2.5%